Efficacy of smoking cessation therapy alone or integrated with prolonged exposure therapy for smokers with PTSD: Study protocol for a randomized controlled trial.
Efficacy of smoking cessation therapy alone or integrated with prolonged exposure therapy for smokers with PTSD: Study protocol for a randomized controlled trial.
复制标题
单独戒烟治疗或与长期暴露治疗相结合对患有创伤后应激障碍 (PTSD) 的吸烟者的疗效:随机对照试验的研究方案。
DOI:
10.1016/j.cct.2016.08.012
复制
发表时间:
2016
影响因子:
2.2
通讯作者:
Rosenfield,David
中科院分区:
文献类型:
--
作者:
Powers,MarkB;Kauffman,BrookeY;Kleinsasser,AnneL;Lee-Furman,Eunjung;Smits,JasperAJ;Zvolensky,MichaelJ;Rosenfield,David
Posttraumatic stress disorder (PTSD) is related to an increased risk of smoking cessation failure. In fact, the quit rate in smokers with PTSD (23.2%) is one of the lowest of all mental disorders. Features of PTSD that contribute to smokers' progression to nicotine dependence and cessation relapse include negative affect, fear, increased arousal, irritability, anger, distress intolerance, and anxiety sensitivity. Anxiety sensitivity is higher in people with PTSD than in any other anxiety disorder except for panic disorder. High anxiety sensitivity is uniquely associated with greater odds of lapse and relapse during quit attempts. Distress intolerance, a perceived or behavioral tendency to not tolerate distress, is related to both the maintenance of PTSD and problems in quitting smoking. Prolonged exposure (PE) and interoceptive exposure (IE) reduce PTSD symptoms, distress intolerance, and anxiety sensitivity. Thus, they emerge as promising candidates to augment standard smoking cessation interventions for individuals with PTSD. The present study tests a 12-session specialized treatment for smokers with PTSD. This Integrated PTSD and Smoking Treatment (IPST) combines cognitive-behavioral therapy and nicotine replacement treatment for smoking cessation (standard care; SC) with PE to target PTSD symptoms and IE to reduce anxiety sensitivity and distress intolerance. Adult smokers (N= 80) with PTSD will be randomly assigned to either: (1) IPST or (2) SC. Primary outcomes are assessed at weeks 0, 6, 8, 10, 14, 16, 22, and 30.
登录
查看更多内容
影响因子:
120.7
作者:
Lasser, K;Boyd, JW;Bor, DH
通讯作者:
Bor, DH
影响因子:
2.2
作者:
Smits,JasperAJ;Kauffman,BrookeY;Lee-Furman,Eunjung;Zvolensky,MichaelJ;Otto,MichaelW;Piper,MeganE;Powers,MarkB;Rosenfield,David
通讯作者:
Rosenfield,David
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
Jasper A. J. Smits;Mark B. Powers;Angela C. Berry;M. Otto
通讯作者:
M. Otto
影响因子:
--
作者:
Kessler, RC;Berglund, P;Walters, EE
通讯作者:
Walters, EE
DOI:
10.1016/s0005-7916(00)00012-4
发表时间:
2000-06-01
影响因子:
1.8
作者:
Devilly, GJ;Borkovec, TD
通讯作者:
Borkovec, TD